These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 28924996)
1. Hyperlipidaemia presenting as palmoplantar pain. Anthony EP; Lichtblau BJ; McCormack C Australas J Dermatol; 2018 Aug; 59(3):e213-e214. PubMed ID: 28924996 [No Abstract] [Full Text] [Related]
2. Rosuvastatin may stabilize vulnerable carotid plaques and reduce carotid intima media thickness in patients with hyperlipidemia. Liu T; Meng XY; Li T; Zhang DY; Zhou YH; Han QF; Wang LH; Wu L; Yao HC Int J Cardiol; 2016 Jun; 212():20-1. PubMed ID: 27016705 [No Abstract] [Full Text] [Related]
3. Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study). Calza L; Magistrelli E; Colangeli V; Borderi M; Bussini L; Bon I; Re MC; Viale P Infect Dis (Lond); 2017 Oct; 49(10):737-747. PubMed ID: 28683645 [TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up on tocilizumab treatment of AA amyloidosis secondary to polyarteritis nodosa. Ostrovršnik J; Hočevar A; Lestan B; Sodin Šemrl S; Lakota K; Tomšič M Amyloid; 2016 Dec; 23(4):260-261. PubMed ID: 27791393 [No Abstract] [Full Text] [Related]
5. Novel treatment of painful plantar keratoderma in pachyonychia congenita using topical sirolimus. Teng JMC; Bartholomew FB; Patel V; Sun G Clin Exp Dermatol; 2018 Dec; 43(8):968-971. PubMed ID: 29882237 [No Abstract] [Full Text] [Related]
7. [Non-alcoholic hepatic steatosis: the role of policosanols in associated hyperlipidemia]. Musto D; Martorelli L; Russo M; Esposito G; Amato MR; Esposito P; Riegler G Minerva Gastroenterol Dietol; 2010 Dec; 56(4):389-95. PubMed ID: 21139538 [TBL] [Abstract][Full Text] [Related]
8. Unmet need in the hyperlipidaemia population with high risk of cardiovascular disease: a targeted literature review of observational studies. Mitchell S; Roso S; Samuel M; Pladevall-Vila M BMC Cardiovasc Disord; 2016 Apr; 16():74. PubMed ID: 27114245 [TBL] [Abstract][Full Text] [Related]
9. Advances in the management of hyperlipidemia-induced atherosclerosis. Tannock LR Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):369-83. PubMed ID: 18327996 [TBL] [Abstract][Full Text] [Related]
14. Update on statins and other lipid-lowering drugs. Miller CA Geriatr Nurs; 2001; 22(5):276-7. PubMed ID: 11606910 [No Abstract] [Full Text] [Related]
15. Pyrexia of unknown origin associated with rosuvastatin. Liew KC; Anpalahan M; Wadhwa V Intern Med J; 2016 Oct; 46(10):1225-1226. PubMed ID: 27734614 [No Abstract] [Full Text] [Related]
19. Atorvastatin: in the management of hyperlipidaemia. Ray SK; Rege NN J Postgrad Med; 2000; 46(3):242-3. PubMed ID: 11298482 [No Abstract] [Full Text] [Related]
20. Meta-Analysis Comparing Rosuvastatin and Atorvastatin in Reducing Concentration of C-Reactive Protein in Patients With Hyperlipidemia. Ma Q; Zhou Y; Zhai G; Gao F; Zhang L; Wang J; Yang Q; Cheng W Angiology; 2016 Jul; 67(6):526-35. PubMed ID: 26271127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]